Mutations of the Epidermal Growth Factor Receptor Gene in Triple-Negative Breast Cancer

PURPOSE: Epidermal growth factor receptor (EGFR) is considered a potential therapeutic target for anti-EGFR therapy in triple-negative breast cancer (TNBC). However, the frequency of EGFR gene mutation in TNBC is low and varies with ethnicity. This study aimed to investigate the incidence of EGFR ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Aeri, Jang, Min Hye, Lee, Soo Jung, Bae, Young Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500398/
https://www.ncbi.nlm.nih.gov/pubmed/28690651
http://dx.doi.org/10.4048/jbc.2017.20.2.150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500398/
https://www.ncbi.nlm.nih.gov/pubmed/28690651
http://dx.doi.org/10.4048/jbc.2017.20.2.150

Ejemplares similares